Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study

Abstract Background Impaired intestinal barrier function can enable passage of enteric microorganisms into the bloodstream and lead to nosocomial bloodstream infections during critical illness. We aimed to determine the relative importance of gut translocation as a source for ICU-acquired enterococc...

Full description

Bibliographic Details
Main Authors: Meri R. J. Varkila, Diana M. Verboom, Lennie P. G. Derde, Tom van der Poll, Marc J. M. Bonten, Olaf L. Cremer, the MARS consortium
Format: Article
Language:English
Published: SpringerOpen 2024-03-01
Series:Annals of Intensive Care
Subjects:
Online Access:https://doi.org/10.1186/s13613-024-01280-8
_version_ 1827300835776790528
author Meri R. J. Varkila
Diana M. Verboom
Lennie P. G. Derde
Tom van der Poll
Marc J. M. Bonten
Olaf L. Cremer
the MARS consortium
author_facet Meri R. J. Varkila
Diana M. Verboom
Lennie P. G. Derde
Tom van der Poll
Marc J. M. Bonten
Olaf L. Cremer
the MARS consortium
author_sort Meri R. J. Varkila
collection DOAJ
description Abstract Background Impaired intestinal barrier function can enable passage of enteric microorganisms into the bloodstream and lead to nosocomial bloodstream infections during critical illness. We aimed to determine the relative importance of gut translocation as a source for ICU-acquired enterococcal bacteremia of unknown origin. Methods We conducted a nested case–control study in two mixed medical-surgical tertiary ICUs in the Netherlands among patients enrolled between 2011 and 2018. We selected 72 cases with ICU-acquired bacteremia due to enterococci (which are known gastrointestinal tract commensals) and 137 matched controls with bacteremia due to coagulase-negative staphylococci (CoNS) (which are of non-intestinal origin). We measured intestinal fatty acid-binding protein, trefoil factor-3, and citrulline 48 h before bacteremia onset. A composite measure for Gut Barrier Injury (GBI) was calculated as the sum of standardized z-scores for each biomarker plus a clinical gastrointestinal failure score. Results No single biomarker yielded statistically significant differences between cases and controls. Median composite GBI was higher in cases than in controls (0.58, IQR − 0.36–1.69 vs. 0.32, IQR − 0.53–1.57, p = 0.33) and higher composite measures of GBI correlated with higher disease severity and ICU mortality (p < 0.001). In multivariable analysis, higher composite GBI was not significantly associated with increased occurrence of enterococcal bacteremia relative to CoNS bacteremia (adjusted OR 1.12 95% CI 0.93–1.34, p = 0.22). Conclusions We could not demonstrate an association between biomarkers of gastrointestinal barrier dysfunction and an increased occurrence of bacteremia due to gut compared to skin flora during critical illness, suggesting against bacterial translocation as a major vector for acquisition of nosocomial bloodstream infections in the ICU.
first_indexed 2024-04-24T16:12:52Z
format Article
id doaj.art-184a0a24672c4ca9bd68f8cca75118fb
institution Directory Open Access Journal
issn 2110-5820
language English
last_indexed 2024-04-24T16:12:52Z
publishDate 2024-03-01
publisher SpringerOpen
record_format Article
series Annals of Intensive Care
spelling doaj.art-184a0a24672c4ca9bd68f8cca75118fb2024-03-31T11:35:29ZengSpringerOpenAnnals of Intensive Care2110-58202024-03-0114111010.1186/s13613-024-01280-8Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control studyMeri R. J. Varkila0Diana M. Verboom1Lennie P. G. Derde2Tom van der Poll3Marc J. M. Bonten4Olaf L. Cremer5the MARS consortiumJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht UniversityJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht UniversityDepartment of Intensive Care Medicine, University Medical Center UtrechtCenter for Experimental and Molecular Medicine, Division of Infectious Diseases, Amsterdam University Medical Centers, University of AmsterdamJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht UniversityJulius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht UniversityAbstract Background Impaired intestinal barrier function can enable passage of enteric microorganisms into the bloodstream and lead to nosocomial bloodstream infections during critical illness. We aimed to determine the relative importance of gut translocation as a source for ICU-acquired enterococcal bacteremia of unknown origin. Methods We conducted a nested case–control study in two mixed medical-surgical tertiary ICUs in the Netherlands among patients enrolled between 2011 and 2018. We selected 72 cases with ICU-acquired bacteremia due to enterococci (which are known gastrointestinal tract commensals) and 137 matched controls with bacteremia due to coagulase-negative staphylococci (CoNS) (which are of non-intestinal origin). We measured intestinal fatty acid-binding protein, trefoil factor-3, and citrulline 48 h before bacteremia onset. A composite measure for Gut Barrier Injury (GBI) was calculated as the sum of standardized z-scores for each biomarker plus a clinical gastrointestinal failure score. Results No single biomarker yielded statistically significant differences between cases and controls. Median composite GBI was higher in cases than in controls (0.58, IQR − 0.36–1.69 vs. 0.32, IQR − 0.53–1.57, p = 0.33) and higher composite measures of GBI correlated with higher disease severity and ICU mortality (p < 0.001). In multivariable analysis, higher composite GBI was not significantly associated with increased occurrence of enterococcal bacteremia relative to CoNS bacteremia (adjusted OR 1.12 95% CI 0.93–1.34, p = 0.22). Conclusions We could not demonstrate an association between biomarkers of gastrointestinal barrier dysfunction and an increased occurrence of bacteremia due to gut compared to skin flora during critical illness, suggesting against bacterial translocation as a major vector for acquisition of nosocomial bloodstream infections in the ICU.https://doi.org/10.1186/s13613-024-01280-8BacteremiaIntensive care unitBloodstream infectionBacterial translocationGut barrierGastrointestinal failure
spellingShingle Meri R. J. Varkila
Diana M. Verboom
Lennie P. G. Derde
Tom van der Poll
Marc J. M. Bonten
Olaf L. Cremer
the MARS consortium
Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study
Annals of Intensive Care
Bacteremia
Intensive care unit
Bloodstream infection
Bacterial translocation
Gut barrier
Gastrointestinal failure
title Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study
title_full Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study
title_fullStr Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study
title_full_unstemmed Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study
title_short Gut barrier dysfunction and the risk of ICU-acquired bacteremia- a case–control study
title_sort gut barrier dysfunction and the risk of icu acquired bacteremia a case control study
topic Bacteremia
Intensive care unit
Bloodstream infection
Bacterial translocation
Gut barrier
Gastrointestinal failure
url https://doi.org/10.1186/s13613-024-01280-8
work_keys_str_mv AT merirjvarkila gutbarrierdysfunctionandtheriskoficuacquiredbacteremiaacasecontrolstudy
AT dianamverboom gutbarrierdysfunctionandtheriskoficuacquiredbacteremiaacasecontrolstudy
AT lenniepgderde gutbarrierdysfunctionandtheriskoficuacquiredbacteremiaacasecontrolstudy
AT tomvanderpoll gutbarrierdysfunctionandtheriskoficuacquiredbacteremiaacasecontrolstudy
AT marcjmbonten gutbarrierdysfunctionandtheriskoficuacquiredbacteremiaacasecontrolstudy
AT olaflcremer gutbarrierdysfunctionandtheriskoficuacquiredbacteremiaacasecontrolstudy
AT themarsconsortium gutbarrierdysfunctionandtheriskoficuacquiredbacteremiaacasecontrolstudy